Development of lentiviral vectors manufacturing process using a HEK293 producer cell line

被引：0
|
作者：
Audy, A. [1 ,2 ]
Robert, M. A. [1 ,2 ]
Chahal, P. S. [2 ]
Gilbert, R. [2 ]
Gaillet, B. [1 ]
机构：
[1] Univ Laval, Dept Chem Engn, Quebec City, PQ, Canada
[2] Natl Res Council Canada, Montreal, PQ, Canada
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P385
引用
收藏
页码：A163 / A163
页数：1
相关论文
共 50 条
  • [21] Influence of HEK293 metabolism on the production of viral vectors and vaccine
    Petiot, Emma
    Cuperlovic-Culf, Miroslava
    Shen, Chun Fang
    Kamen, Amine
    [J]. VACCINE, 2015, 33 (44) : 5974 - 5981
  • [22] Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures
    Ansorge, Sven
    Lanthier, Stephane
    Transfiguracion, Julia
    Durocher, Yves
    Henry, Olivier
    Kamen, Amine
    [J]. JOURNAL OF GENE MEDICINE, 2009, 11 (10): : 868 - 876
  • [23] Author Correction: Evolution from adherent to suspension: systems biology of HEK293 cell line development
    Magdalena Malm
    Rasool Saghaleyni
    Magnus Lundqvist
    Marco Giudici
    Veronique Chotteau
    Ray Field
    Paul G. Varley
    Diane Hatton
    Luigi Grassi
    Thomas Svensson
    Jens Nielsen
    Johan Rockberg
    [J]. Scientific Reports, 11
  • [24] Development and upscale of HEK293 triple transfection process in single-use bioreactors for industrial manufacture of AAV vectors
    Guianvarc'h, L.
    Boussicault, F.
    Le Bec, C.
    Mingozzi, F.
    Mavilio, F.
    Hebben, M.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A70 - A71
  • [25] State of Producer Cell Development for Lentiviral Vector Manufacturing
    Challener, Cynthia A.
    [J]. BIOPHARM INTERNATIONAL, 2023, 36 (07)
  • [26] Development of a Novel Cell Culture Medium for AAV Production with Multiple HEK293 Lineages and Process Optimization
    Haywood, Jessica J.
    Schrag, Kim
    Hellman, Kate
    Stegemann, Nathan
    McLaughlin, Katelyn
    Javalet, Charlotte
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 749 - 749
  • [27] Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells
    Blessing, Daniel
    Vachey, Gabriel
    Pythoud, Catherine
    Rey, Maria
    Padrun, Vivianne
    Wurm, Florian M.
    Schneider, Bernard L.
    Deglon, Nicole
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 14 - 26
  • [28] Scalable and high-titre lentiviral vector production from cGMP-compliant clonal suspension HEK293 cell line
    Krakowiak, J.
    Tomas, H.
    Keller, L. E.
    Efstathiou, A.
    Parker-Manuel, R.
    Macchiarulo, E.
    Zhang, L.
    Liu, Q.
    Cawood, R.
    Payne, T.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A32 - A33
  • [29] Our Proprietary Manufacturing Process, mAAVRx, Enables Improved AAV Manufacturing in Different Suspension HEK293 Systems
    Jia, Nannan
    Deng, June
    Hu, Shiliang
    Chen, Yinxing
    Walsh, Noel
    Lee, William
    Wu, Carmen
    Drouin, Lauren
    DiGioia, Nicholas
    Liao, Jing
    Hebben, Matthias
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 233 - 233
  • [30] Novel Constitutive Producer Cell Line & GMP Compatible Dowstream Process for Lentiviral Vector Manufacturing
    Tomas, Helio A.
    Oliveiras, Ana S.
    Rodrigues, Ana F.
    Faria, Tiago
    Carrondo, Manuel J. T.
    Alves, Paula M.
    Peixoto, Cristina
    Coroadinha, Ana S.
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 152 - 152
12345